These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35243952)

  • 41. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.
    Benza RL; Gomberg-Maitland M; Miller DP; Frost A; Frantz RP; Foreman AJ; Badesch DB; McGoon MD
    Chest; 2012 Feb; 141(2):354-362. PubMed ID: 21680644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
    Kylhammar D; Persson L; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class.
    Dufour R; Pruett J; Hu N; Lickert C; Stemkowski S; Tsang Y; Lane D; Drake W
    J Med Econ; 2017 Nov; 20(11):1178-1186. PubMed ID: 28762848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data.
    Didden EM; Lee E; Wyckmans J; Quinn D; Perchenet L
    Pulm Circ; 2023 Jan; 13(1):e12188. PubMed ID: 36694845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations Between Sildenafil Use and Changes in Days of Hospitalization in a Population With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
    Yang X; Sanders KN; Mardekian J; Mychaskiw MA; Thomas J
    Clin Ther; 2015 May; 37(5):1055-63. PubMed ID: 25818118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis.
    Swift AJ; Lu H; Uthoff J; Garg P; Cogliano M; Taylor J; Metherall P; Zhou S; Johns CS; Alabed S; Condliffe RA; Lawrie A; Wild JM; Kiely DG
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(2):236-245. PubMed ID: 31998956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of m
    Wang D; Mo Y; Zhang D; Bai Y
    Front Immunol; 2022; 13():1014509. PubMed ID: 36544768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-World Analysis of Treatment Patterns Among Hospitalized Patients with Pulmonary Arterial Hypertension.
    Ogbomo A; Tsang Y; Kariburyo F; Tsai WL; Panjabi S
    Pulm Ther; 2021 Dec; 7(2):575-590. PubMed ID: 34699029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Right Atrial Conduit Phase Emptying Predicts Risk of Adverse Events in Pediatric Pulmonary Arterial Hypertension.
    Frank BS; Schafer M; Thomas TM; Haxel C; Ivy DD; Jone PN
    J Am Soc Echocardiogr; 2020 Aug; 33(8):1006-1013. PubMed ID: 32336608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Real-world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States.
    Pizzicato LN; Nadipelli VR; Governor S; Mao J; Lanes S; Butler J; Pepe RS; Phatak H; El-Kersh K
    Pulm Circ; 2022 Apr; 12(2):e12090. PubMed ID: 35795495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus.
    Song W; Chu S; Yang K; Sun X; Xia H; Mei C; Zhao Y; Wu J
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2511-2517. PubMed ID: 34247927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
    Stollfuss B; Richter M; Drömann D; Klose H; Schwaiblmair M; Gruenig E; Ewert R; Kirchner MC; Kleinjung F; Irrgang V; Mueller C
    J Med Internet Res; 2021 Oct; 23(10):e25163. PubMed ID: 34623313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate?
    Moonen A; Garsia R; Youssef P; Torzillo P; Corte T; Boehm C; Cordina R; Celermajer D; Lau E
    Intern Med J; 2017 Oct; 47(10):1124-1128. PubMed ID: 28560817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Value of Early Risk Stratification in Pediatric Pulmonary Arterial Hypertension.
    Ablonczy L; Ferenci T; Somoskövi O; Osváth R; Reusz GS; Kis E
    Transplant Proc; 2021 Jun; 53(5):1439-1442. PubMed ID: 33622612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accuracy of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data: A Systematic Review.
    Gillmeyer KR; Lee MM; Link AP; Klings ES; Rinne ST; Wiener RS
    Chest; 2019 Apr; 155(4):680-688. PubMed ID: 30471268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.